|
|
|
|
Report No. : |
488355 |
|
Report Date : |
27.01.2018 |
IDENTIFICATION DETAILS
|
Name : |
MANKIND PHARMA LIMITED |
|
|
|
|
Formerly Known
As : |
MANKIND PHARMA PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
208, Okhla Industrial Estate, Phase – III, New Delhi-110020 |
|
Tel. No.: |
91-11-46541111 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2016 |
|
|
|
|
Date of
Incorporation : |
03.07.1991 |
|
|
|
|
Com. Reg. No.: |
55-044843 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 200.294 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U74899DL1991PLC044843 |
|
|
|
|
IEC No.: |
0593044312 |
|
|
|
|
GST No.: |
07AAACM9401C1ZX |
|
|
|
|
TIN No.: |
07290281758 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACM9401C |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturing, Marketing and Trading of Pharmaceutical and Health Care Products. [Registered Activity] |
|
|
|
|
No. of Employees
: |
Not Divulged |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A+ |
|
Credit Rating |
Explanation |
Rating Comments |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
Maximum Credit Limit : |
USD 59045300 |
|
|
|
|
Status : |
Excellent |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Mankind Pharma Limited was incorporated in the year 1991. It is engaged in trading and manufacturing of pharmaceuticals and health care products. For the financial year 2016, the company has achieved a YOY growth of 17.41% (Approximately) and has achieved a Good Net Profit margin of 14.90% (Approximately). The robust financial profile of the company is marked by healthy networth base along with strong debt coverage indicators due to debt free balance sheet profile. The company has given an output of Rupees 234.25 in the EPS section as compared to its original face value of Rupees 10. Rating also derives strength from company’s established track record of business. However, rating strengths are partially offset by unfavouarble gap between trade payables and trade receivables. Business is active. Payment terms are reported to be regular. In view of aforesaid, the company can be considered normal for business dealings at usual trade terms and conditions. Note: As per Registrar of Companies, the date of balance sheet i.e financials filed is shown as 31st March, 2017 but documents related to the financials for the year 2017 are not available from any sources. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.06.2017) |
Current Rating (30.09.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
NOT AVAILABLE
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction) LISTING
STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 27.01.2018.
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION DECLINED
MANAGEMENT NON-COOPERATIVE
(Contact No: 91-11-46541375)
LOCATIONS
|
Registered Office : |
208, Okhla Industrial Estate, Phase – III, New Delhi-110020, India |
|
Tel. No.: |
91-11-46541111/ 46541375 (30 Lines) |
|
Fax No.: |
91-11-46541382 |
|
E-Mail : |
sanjeev.singh@mankindpharma.com pradeep.chugh@makindpharma.com |
|
Website : |
|
|
|
|
|
Corporate Office : |
236, Okhla Industrial Estate, Phase – III, New Delhi – 110020, India |
|
Tel. No.: |
91-11-46546060/ 46541400 |
|
|
|
|
Factory 1 : |
Poanta Sahib (Himachal Pradesh), |
|
|
|
|
Factory 2 : |
Plot No. 191 E, Sector 4, IMT Manesevar, Gurguram, Haryana, India |
DIRECTORS
AS ON 31.03.2017
|
Name : |
Mr. Ramesh Chand Juneja |
|
Designation : |
Whole Time Director |
|
Address : |
B-7, Vasant Marg, 2nd Floor, Vasant Vihar, New Delhi -
110057, India |
|
Date of Birth/Age : |
18.07.1950 |
|
Date of Appointment : |
15.05.2014 |
|
PAN No.: |
AEJPJ9773L |
|
DIN No.: |
00283399 |
|
|
|
|
Name : |
Mr. Rajeev Juneja |
|
Designation : |
Whole-time director |
|
Address : |
F-42, Radhey Mohan Drive, Jonapur, Mehrauli, New
Delhi, India |
|
Date of Birth/Age : |
28.07.1965 |
|
Date of Appointment : |
22.12.1992 |
|
PAN No.: |
ADIPJ0332M |
|
DIN No.: |
00283481 |
|
|
|
|
Name : |
Mr. Prem Kumar Arora |
|
Designation : |
Whole-time director |
|
Address : |
A-1/9, Vasant Vihar, New Delhi-110052, India |
|
Date of Birth/Age : |
11.09.1938 |
|
Date of Appointment : |
01.05.2006 |
|
DIN No.: |
00704226 |
|
|
|
|
Name : |
Mrs. Sheetal Arora |
|
Designation : |
Managing Director |
|
Address : |
A-1/9, Vasant Vihar, New Delhi-110052, India |
|
Date of Birth/Age : |
18.11.1975 |
|
PAN No.: |
ADPPA2599C |
|
Date of Appointment : |
21.09.2007 |
|
DIN No.: |
00704292 |
|
|
|
|
Name : |
Mr. Arjun Juneja |
|
Designation : |
Whole-time director |
|
Address : |
B-7, Vasant Marg, 2nd Floor, Vasant Vihar, New
Delhi-110057, India |
|
Date of Birth/Age : |
09.05.1986 |
|
Date of Appointment : |
15.05.2009 |
|
PAN No.: |
AGEPJ3227A |
|
DIN No.: |
00704349 |
|
|
|
|
Name : |
Mr. Surendra Lunia |
|
Designation : |
Director |
|
Address : |
5010, Phase –IV, DLF, Gurgaon – 122011, Haryana, India |
|
Date of Appointment : |
19.02.2015 |
|
DIN No.: |
00121156 |
|
|
|
|
Name : |
Ms. Prabha Arora |
|
Designation : |
Director |
|
Address : |
A-1/9, Vasant Vihar, New Delhi - 110052, India |
|
Date of Birth/Age : |
07.07.1948 |
|
Date of Appointment : |
06.02.1995 |
|
PAN No.: |
ADPPA3875K |
|
DIN No.: |
00283527 |
|
|
|
|
Name : |
Mr. Sandip Sharma |
|
Designation : |
Director |
|
Address : |
27 Oak Drive Dlf, Kh No- 1137, 1139 DLF, Chhatterpur-110030, Delhi, India |
|
Date of Appointment : |
19.02.2015 |
|
DIN No.: |
03248306 |
|
|
|
|
Name : |
Mr. Anuj Girotra |
|
Designation : |
Alternate Director |
|
Address : |
53 Grange Road, #06-04, Spring Grove, Singapore 249565 Singapore |
|
Date of Appointment : |
05.03.2016 |
|
DIN No.: |
06401549 |
|
|
|
|
Name : |
Mr. Leonard Lee Kim |
|
Designation : |
Director |
|
Address : |
9, Ardmore Park, #15-01 Singapore 259955, Singapore |
|
Date of Appointment : |
14.03.2016 |
|
DIN No.: |
07379167 |
|
|
|
|
Name : |
Mr. Satish Kumar Sharma |
|
Designation : |
Wholetime Director |
|
Address : |
Vill. Po Duloth Jat, Distt. Mohindergarh-123021, Haryana, India |
|
Date of Appointment : |
23.09.2016 |
|
DIN No.: |
07615602 |
KEY EXECUTIVES
|
Name : |
Mr. Rajeev Juneja |
|
Designation : |
Chief Executive Officer (KMP) |
|
Address : |
F-42, Radhey Mohan Drive, Jonapur, Mehrauli, New
Delhi, India |
|
Date of Appointment : |
15.05.2014 |
|
PAN No.: |
ADIPJ0332M |
|
|
|
|
Name : |
Mr. Pradeep Chugh |
|
Designation : |
Company Secretary |
|
Address : |
94, 2nd Floor, Near Xion International School Sector 5, Part 3, Gurgaon-122001, Haryana, India |
|
Date of Appointment : |
23.09.2016 |
|
PAN No.: |
AFVPC8199Q |
|
|
|
|
Name : |
Mr. Ashutosh Kumar Dhawan |
|
Designation : |
Chief Financial Officer (KMP) |
|
Address : |
7036, Sector - B, Pocket – 10, Vasant Kunj, New Delhi-110070, India |
|
Date of Appointment : |
17.06.2016 |
|
PAN No.: |
AADPD2236J |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON 31.03.2017
|
Names of Shareholders |
No. of Shares |
Percentage of Holding |
|
Ramesh Juneja |
588 |
0.00 |
|
Rajeev Juneja |
4225899 |
21.10 |
|
Sheetal Arora |
2494088 |
12.45 |
|
Arjun Juneja |
859247 |
4.29 |
|
Prem Kumar Arora |
3156 |
0.02 |
|
Poonam Juneja |
5692378 |
28.42 |
|
Prabha Arora |
2494088 |
12.45 |
|
Puja Juneja |
2056741 |
10.27 |
|
Cairnhill CIPEF Limited |
1914612 |
9.56 |
|
Cairnhill CGPE Limited |
288625 |
1.44 |
|
|
|
|
|
Total |
20029422 |
100.00 |
AS ON 23.09.2017
|
Equity Share Breakup |
Percentage of Holding |
|
Category |
|
|
Promoters
– Individual/Hindu Undivided Family (Indian) |
89.00 |
|
Public/
Other than Promoters – Body Corporate |
11.00 |
|
|
|
|
Total |
100.00 |

BUSINESS DETAILS
|
Line of Business : |
Manufacturing, Marketing and Trading of Pharmaceutical and Health Care Products. [Registered Activity] |
||||
|
|
|
||||
|
Products/ Services : |
|
||||
|
|
|
||||
|
Brand Names : |
‘’Mankind’’ |
||||
|
|
|
||||
|
Agencies Held : |
Not Available |
||||
|
|
|
||||
|
Exports : |
Not Divulged |
||||
|
|
|
||||
|
Imports : |
Not Divulged |
||||
|
|
|
||||
|
Terms : |
|
||||
|
Selling : |
Not Divulged |
||||
|
|
|
||||
|
Purchasing : |
Not Divulged |
PRODUCTION STATUS: NOT AVAILABLE
GENERAL INFORMATION
|
Suppliers : |
|
|||||||||||||||
|
|
|
|||||||||||||||
|
Customers : |
|
|||||||||||||||
|
|
|
|||||||||||||||
|
No. of Employees : |
Not Divulged |
|||||||||||||||
|
|
|
|||||||||||||||
|
Bankers : |
· ICICI Bank Limited Landmarkrace Cource Circle, Alkapuri, Baroda - 390015, Gujarat, India · Citibank N.A Jeevan Bharti Building, 4th Floor, 124, Connaught Circus, Connaught Place, New Delhi - 110001, India · HDFC Bank Limited |
|||||||||||||||
|
|
|
|||||||||||||||
|
Facilities : |
|
|
Financial Institution : |
· Citicorp Finance (India) Limited |
|
|
|
|
Auditors 1 : |
|
|
Name : |
Bhagi Bhardwaj
Gaur and Company Chartered Accountants |
|
Address : |
2952-53/2,
Sangtrashan, D.B Gupta Road, Paharganj, New Delhi-110055, India |
|
Income-tax
PAN of auditor or auditor's firm : |
AADFB8409K |
|
|
|
|
Auditors 2 : |
|
|
Name : |
Deloitte Haskins and Sells LLP Chartered Accountants |
|
Address : |
7th Floor, Building - 10, Tower B, DLF Cyber City Complex, DLF City Phase-II, Gurgaon –122002, Haryana, India |
|
Income-tax
PAN of auditor or auditor's firm : |
AACFD4815A |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Subsidiary
Companies : |
· Life Star Pharma Limited, India (U24232DL2004PTC131232) · Magnet Labs Private Limited, India (U51397DL1998PTC093307) · Medi Pack Innovations Private Limited, India (U28113DL2012PTC237207) · Akasia Magnum Hospitality Private Limited, India [U55101HR2003PTC035032] · Appian Associates Infrastructure Private Limited, India [U45201HR2006PTC052011] · Jaspack Industries Private Limited, India [U36912DL2015PTC277915] · Mahananda Spa and Resorts Private Limited, India [U55101UR2009PTC032889] · Mithras Translogic Private Limited, India [U60200DL1991PTC043980] · Packtime Innovations Private Limited, India [U36912DL2015PTC281265] · Prolijune Life Sciences Private Limited, India · (U51500DL2006PTC153155) · Shree Jee Laboratory Private Limited, India [U24232DL2011PTC272907] · Broadway Hospitality Services Private Limited, India [U85110DL2003PTC123280] · Pavi Buildwell Private LimiteD, India [U70200DL2012PTC237294] · Gyan Infrastructure Company Private Limited, India [U70101DL1997PTC085909] · Lifestar Pharma LLC · Mankind Pharma Pte Limited · Superba Developers |
|
|
|
|
Associate : |
Penta Latex |
|
|
|
|
Enterprises which are owned, or have
significant influence of or are partners with Key management personnel and
their relatives : |
· A To Z Packers · A S Packers · Copmed Pharmaceuticals Private Limited, India [U74899DL1988PTC033151] · J. K. Printpack Mediforce Healthcare Private Limited, India [U51397up2001ptc025873] · N. S. Industries · Next Wave (India) · Pharma Force Lab Printman · Relax Pharmaceuticals Private Limited, India [U24231UP1997PTC022390] · Sirmour Remedies Private Limited, India [U15311HP1989PTC009770] · Anm Pharma Private Limited, India [U24233DL2013PTC262682] · Paonta Process Equipment · Rashi Apparels Private Limited, India (U74899DL1991PTC043986) · Casablanca Securities Private Limited, India [U67120DL1996PTC078045] · Indu Buildwell Private Limited, India [U45201DL2005PTC132765] · Alankrit Handicrafts Private Limited, India (U99999DL1974PTC007499) · Superba Buildwell · Luxor Metaltec India Private Limited, India (U74899DL1976PTC008081) · Rashmi Exports Private Limited, India [U74899DL1991PTC043979] · Teen Murti Products Private Limited, India [U74899DL1991PTC045731] · Star Infra Developers Private Limited, India [U45400DL2010PTC205809] · Om Sai Pharma Pack |
CAPITAL STRUCTURE
AFTER 30.09.2016
Authorised Capital : INR
410.000 Million
Issued, Subscribed & Paid-up Capital : INR 400.588 Million
AS ON 31.03.2016
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
25000000 |
Equity Shares |
INR 10/- each |
INR 250.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
20029422 |
Equity Shares |
INR 10/- each |
INR 200.294
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in INR Million]
|
SOURCES OF FUNDS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
200.294 |
200.294 |
200.294 |
|
(b) Reserves & Surplus |
20465.575 |
19386.198 |
15354.723 |
|
(c) Money
received against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2)
Share Application money pending allotment |
0.000 |
0.000 |
0.000 |
|
Total Shareholders’ Funds (1) + (2) |
20665.869 |
19586.492 |
15555.017 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) Long-term borrowings |
0.000 |
0.178 |
0.000 |
|
(b)
Deferred tax liabilities (Net) |
0.000 |
2.937 |
44.481 |
|
(c) Other long term liabilities |
0.000 |
0.000 |
220.675 |
|
(d) long-term provisions |
148.976 |
89.911 |
48.404 |
|
Total Non-current Liabilities (3) |
148.976 |
93.026 |
313.560 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
0.000 |
0.000 |
0.340 |
|
(b) Trade payables |
3266.691 |
2839.744 |
1757.908 |
|
(c) Other current
liabilities |
673.651 |
563.819 |
1088.350 |
|
(d) Short-term provisions |
14.576 |
11.425 |
3094.169 |
|
Total Current Liabilities (4) |
3954.918 |
3414.988 |
5940.767 |
|
|
|
|
|
|
TOTAL |
24769.763 |
23094.506 |
21809.344 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
2414.540 |
2166.380 |
1953.742 |
|
(ii) Intangible
Assets |
61.130 |
49.084 |
73.135 |
|
(iii) Capital
work-in-progress |
765.694 |
419.923 |
202.646 |
|
(iv)
Intangible assets under development |
0.000 |
34.985 |
11.064 |
|
(b) Non-current Investments |
3154.902 |
2560.060 |
1095.071 |
|
(c) Deferred tax assets (net) |
12.598 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
5527.625 |
4009.420 |
1938.709 |
|
(e) Other Non-current assets |
1.744 |
2.108 |
410.220 |
|
Total Non-Current Assets |
11938.233 |
9241.960 |
5684.587 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current
investments |
5331.642 |
6884.746 |
6890.536 |
|
(b) Inventories |
4101.506 |
3985.663 |
3371.861 |
|
(c) Trade
receivables |
1573.879 |
1690.148 |
1316.920 |
|
(d) Cash and cash
equivalents |
718.069 |
405.901 |
999.576 |
|
(e) Short-term
loans and advances |
958.107 |
882.637 |
3545.864 |
|
(f) Other current
assets |
148.327 |
3.451 |
0.000 |
|
Total Current
Assets |
12831.530 |
13852.546 |
16124.757 |
|
|
|
|
|
|
TOTAL |
24769.763 |
23094.506 |
21809.344 |
PROFIT & LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
|
|
SALES |
|
|
|
|
|
|
|
Revenue from
Operations |
31495.083 |
26824.364 |
22885.864 |
|
|
|
Other Income |
727.317 |
733.378 |
436.086 |
|
|
|
TOTAL (A) |
32222.400 |
27557.742 |
23321.950 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Materials Consumed |
1289.844 |
1263.301 |
1129.821 |
|
|
|
Purchases
of Stock-in-Trade |
10886.390 |
10352.497 |
8664.162 |
|
|
|
Changes
in inventories of finished goods, work-in-progress and Stock-in-Trade |
(125.983) |
(764.393) |
(156.570) |
|
|
|
Employees
benefits expense |
5738.902 |
4809.367 |
3543.082 |
|
|
|
Other
expenses |
7270.964 |
5867.493 |
5005.766 |
|
|
|
CSR Expenditure |
44.315 |
77.691 |
0.000 |
|
|
|
TOTAL
(B) |
25104.432 |
21605.956 |
18186.261 |
|
|
|
|
|
|
|
|
|
PROFIT/(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION (A-B) (C) |
7117.968 |
5951.786 |
5135.689 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL EXPENSES (D) |
14.529 |
14.861 |
14.452 |
|
|
|
|
|
|
|
|
|
|
PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION
(C-D) (E) |
7103.439 |
5936.925 |
5121.237 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/ AMORTISATION (F) |
366.966 |
356.409 |
265.472 |
|
|
|
|
|
|
|
|
|
|
PROFIT/(LOSS)
BEFORE TAX (E-F) (G) |
6736.473 |
5580.516 |
4855.765 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
2044.516 |
1545.145 |
1413.780 |
|
|
|
|
|
|
|
|
|
|
PROFIT/(LOSS)
AFTER TAX (G-H) (I) |
4691.957 |
4035.371 |
3441.985 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export Earnings (FOB basis) |
114.282 |
90.623 |
37.077 |
|
|
|
Earnings on dividend |
330.486 |
0.000 |
0.000 |
|
|
TOTAL EARNINGS |
444.768 |
90.623 |
37.077 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Raw Materials |
0.000 |
0.169 |
96.607 |
|
|
|
Stores &
Spares |
9.783 |
4.254 |
57.674 |
|
|
|
Capital Goods |
151.080 |
121.334 |
0.000 |
|
|
TOTAL IMPORTS |
160.863 |
125.757 |
154.281 |
|
|
|
|
|
|
|
|
|
|
Earnings/(Loss)
Per Share (INR) |
234.25 |
201.47 |
171.85 |
|
CURRENT MATURITIES OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Current
Maturities of Long term debt |
NA |
NA |
NA |
|
|
|
|
|
|
Net cash flows from (used in) operations |
7563.443 |
5498.118 |
9722.898 |
|
|
|
|
|
|
Net cash flows from (used in) operating activities |
4825.400 |
3261.933 |
11189.237 |
KEY RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Average Collection Days (Sundry Debtors /
Income * 365 Days) |
18.24 |
23.00 |
21.00 |
|
|
|
|
|
|
Account Receivables Turnover (Income
/ Sundry Debtors) |
20.01 |
15.87 |
17.38 |
|
|
|
|
|
|
Average Payment Days (Sundry
Creditors / Purchases * 365 Days) |
97.92 |
89.23 |
65.51 |
|
|
|
|
|
|
Inventory Turnover (Operating
Income / Inventories) |
1.74 |
1.49 |
1.52 |
|
|
|
|
|
|
Asset Turnover (Operating
Income / Net Fixed Assets) |
2.20 |
2.23 |
2.29 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Debt Ratio ((Borrowing + Current
Liabilities) / Total Assets) |
0.16 |
0.15 |
0.27 |
|
|
|
|
|
|
Debt Equity Ratio (Total
Liability / Networth) |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
Current Liabilities to Networth (Current
Liabilities / Net Worth) |
0.19 |
0.17 |
0.38 |
|
|
|
|
|
|
Fixed Assets to Networth (Net
Fixed Assets / Networth) |
0.16 |
0.14 |
0.14 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT
/ Financial Charges) |
489.91 |
400.50 |
355.36 |
PROFITABILITY
RATIOS
|
PARTICULARS |
|
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Net Profit Margin ((PAT
/ Sales) * 100) |
% |
14.90 |
15.04 |
15.04 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT
/ Total Assets) * 100) |
% |
18.94 |
17.47 |
15.78 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT
/ Networth) * 100) |
% |
22.70 |
20.60 |
22.13 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Current Ratio (Current Assets /
Current Liabilities) |
3.24 |
4.06 |
2.71 |
|
|
|
|
|
|
Quick Ratio ((Current
Assets – Inventories) / Current Liabilities) |
2.21 |
2.89 |
2.15 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth
/ Total Assets) |
0.83 |
0.85 |
0.71 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts
/ Equity Capital) |
0.00 |
0.00 |
0.00 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total
Current Assets / Total Current Liabilities) |
3.24 |
4.06 |
2.71 |
Total Liability = Short-term
Debt + Long-term Debt + Current Maturities of Long-term debts
FINANCIAL DATA
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Share Capital |
200.294 |
200.294 |
200.294 |
|
Reserves & Surplus |
15354.723 |
19386.198 |
20465.575 |
|
Money received against share warrants |
0.000 |
0.000 |
0.000 |
|
Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Net
worth |
15555.017 |
19586.492 |
20665.869 |
|
|
|
|
|
|
long-term borrowings |
0.000 |
0.178 |
0.000 |
|
Short term borrowings |
0.340 |
0.000 |
0.000 |
|
Total
borrowings |
0.340 |
0.178 |
0.000 |
|
Debt/Equity
ratio |
0.000 |
0.000 |
0.000 |

YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales |
22885.864 |
26824.364 |
31495.083 |
|
|
|
17.209 |
17.412 |

NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales |
22885.864 |
26824.364 |
31495.083 |
|
Profit |
3441.985 |
4035.371 |
4691.957 |
|
|
15.04% |
15.04% |
14.90% |

ABRIDGED
BALANCE SHEET [CONSOLIDATED]
|
SOURCES OF FUNDS |
|
31.03.2016 |
31.03.2015 |
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
|
200.294 |
200.294 |
|
(b) Reserves & Surplus |
|
21968.771 |
20347.470 |
|
(c) Money received against share warrants |
|
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share
Application money pending allotment |
|
0.000 |
0.000 |
|
(3) Minority Interest |
|
296.632 |
155.747 |
|
Total
Shareholders’ Funds (1) + (2) |
|
22465.697 |
20703.511 |
|
|
|
|
|
|
(3)
Non-Current Liabilities |
|
|
|
|
(a) Long-term borrowings |
|
23.994 |
0.178 |
|
(b) Deferred tax liabilities (Net) |
|
3.546 |
4.335 |
|
(c)
Other long term liabilities |
|
100.188 |
160.151 |
|
(d)
long-term provisions |
|
192.600 |
127.171 |
|
Total
Non-current Liabilities (3) |
|
320.328 |
291.835 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a)
Short term borrowings |
|
0.000 |
0.000 |
|
(b)
Trade payables |
|
4221.168 |
3801.495 |
|
(c)
Other current liabilities |
|
906.819 |
520.953 |
|
(d)
Short-term provisions |
|
44.690 |
10.408 |
|
Total
Current Liabilities (4) |
|
5172.677 |
4332.856 |
|
|
|
|
|
|
TOTAL |
|
27958.702 |
25328.202 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a)
Fixed Assets |
|
|
|
|
(i)
Tangible assets |
|
3559.336 |
2717.349 |
|
(ii)
Intangible Assets |
|
61.130 |
49.293 |
|
(iii)
Capital work-in-progress |
|
1464.437 |
436.950 |
|
(iv) Intangible assets under development |
|
0.000 |
35.048 |
|
(b) Non-current
Investments |
|
2053.122 |
2223.505 |
|
(c) Deferred tax assets
(net) |
|
31.430 |
11.496 |
|
(d) Long-term Loan
and Advances |
|
3568.822 |
2726.526 |
|
(e)
Other Non-current assets |
|
922.459 |
399.982 |
|
Total
Non-Current Assets |
|
11660.736 |
8600.149 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a)
Current investments |
|
5963.971 |
7368.655 |
|
(b)
Inventories |
|
6191.090 |
5961.989 |
|
(c)
Trade receivables |
|
1927.078 |
1970.177 |
|
(d)
Cash and cash equivalents |
|
987.019 |
387.913 |
|
(e)
Short-term loans and advances |
|
1077.384 |
1035.798 |
|
(f)
Other current assets |
|
151.424 |
3.521 |
|
Total
Current Assets |
|
16297.966 |
16728.053 |
|
|
|
|
|
|
TOTAL |
|
27958.702 |
25328.202 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
|
31.03.2016 |
31.03.2015 |
|
|
|
SALES |
|
|
|
|
|
|
|
Revenue from Operations |
|
39370.192 |
33231.400 |
|
|
|
Other Income |
|
742.095 |
761.914 |
|
|
|
TOTAL |
|
40112.287 |
33993.314 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Materials Consumed |
|
1703.653 |
1452.209 |
|
|
|
Purchases of Stock-in-Trade |
|
14109.618 |
13424.854 |
|
|
|
Changes in inventories of finished goods, work-in-progress
and Stock-in-Trade |
|
(251.896) |
(942.770) |
|
|
|
Employees benefits expense |
|
7376.070 |
6099.153 |
|
|
|
Other expenses |
|
8940.980 |
7261.768 |
|
|
|
CSR Expenditure |
|
54.315 |
82.991 |
|
|
|
TOTAL |
|
31932.740 |
27378.205 |
|
|
|
|
|
|
|
|
|
PROFIT/(LOSS)
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION |
|
8179.547 |
6615.109 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
|
21.160 |
21.528 |
|
|
|
|
|
|
|
|
|
|
PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION |
|
8158.387 |
6593.581 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
|
420.374 |
385.369 |
|
|
|
|
|
|
|
|
|
|
PROFIT/(LOSS) BEFORE TAX |
|
7738.013 |
6208.212 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
|
2425.443 |
1767.802 |
|
|
|
|
|
|
|
|
|
|
PROFIT (LOSS) FOR
PERIOD BEFORE MINORITY INTEREST |
|
5312.570 |
4440.410 |
|
|
|
|
|
|
|
|
|
Add |
PROFIT (LOSS) OF
MINORITY INTEREST |
|
(91.083) |
(58.670) |
|
|
|
|
|
|
|
|
|
Add |
SHARE OF PROFIT
(LOSS) OF ASSOCIATES |
|
18.161 |
11.314 |
|
|
|
|
|
|
|
|
|
|
PROFIT (LOSS) FOR
PERIOD |
|
5239.648 |
4393.054 |
|
|
|
|
|
|
|
|
|
|
Earnings/(Loss) Per Share (INR) |
|
261.60 |
219.33 |
|
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
No |
|
8 |
Designation of contact person |
No |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
No |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
No |
|
19 |
Major customers |
No |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
No |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
No |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
INDEX OF CHARGES
|
SNO |
SRN |
CHARGE ID |
CHARGE HOLDER NAME |
DATE OF CREATION |
DATE OF
MODIFICATION |
DATE OF SATISFACTION |
AMOUNT |
ADDRESS |
|
1 |
B92245323 |
10468043 |
DIRECTOR OF INDUSTRIES HIMACHAL PRADESH |
04/12/2013 |
- |
- |
3000000.0 |
Single Window Clearance Agency, Paonta SahibDistrict SirmourPAONTA SAHIBHP173025IN |
|
2 |
B14582340 |
10291096 |
DIRECTOR OF INDUSTRIES HIMACHAL PRADESH |
07/06/2011 |
- |
- |
3000000.0 |
SINGLE WINDOW CLEARANCE AGAENCY , PONTA SAHIBDIST; SIRMOURPANTA SAHIBHP173025IN |
|
3 |
G43878784 |
10248498 |
Citi Bank N.A. |
12/10/2010 |
10/03/2017 |
- |
1200000000.0 |
Jeevan Bharti Building, 4th Floor124 Connaught Circus, Connaught PlaceNew DelhiDL110001IN |
|
4 |
C09791385 |
10143837 |
DIRECTOR OF INDUSTRIES, HIMACHAL PRADESH |
16/01/2009 |
- |
28/06/2014 |
3000000.0 |
THROUGH MEMBER SECRETARY,SINGLE WINDOW CLEARANCE AGENCY, PAONTA SAHIBSIRMOURHP173025IN |
|
5 |
B30089601 |
10028667 |
ICICI BANK LIMITED |
09/11/2006 |
04/03/2009 |
10/01/2012 |
31150000.0 |
LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN |
|
6 |
B30326342 |
10142492 |
ICICI BANK LIMITED |
19/02/2009 |
- |
10/01/2012 |
31150000.0 |
LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN |
|
7 |
B12224515 |
10043829 |
ICICI BANK LIMITED |
12/02/2007 |
- |
28/04/2011 |
83250000.0 |
LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN |
|
8 |
B11604162 |
10015497 |
ICICI BANK LIMITED |
16/01/2006 |
- |
28/04/2011 |
83250000.0 |
LANDMARKRACE COURCE CIRCLEALKAPURIBARODAGJ390015IN |
|
9 |
A00517219 |
90037809 |
STATE BANK OF PATIALA |
18/01/2003 |
12/04/2006 |
01/01/2008 |
30000000.0 |
MEERUTMEERUTUP250002IN |
CORPORATE INFORMATION
Mankind Pharma Limited (“hereinafter referred to the Company”) was incorporated on 3 July, 1991. The company is engaged in manufacturing and trading of pharmaceutical and health care products in India.
NATURE OF BUSINESS
During the year, the Company has not changed its nature of business. The Company continues to carry on business of manufacturing, marketing and trading of pharmaceutical products.
SUMMARY OF OPERATIONS
During the year, the total revenue (standalone) from operations of the Company increased from INR 27557.742 Million to INR 32222.400 Million with a growth of 16.92%. For FY 2015-16, the Company’s profit after tax stood at INR 4691.957 Million vis-à-vis INR 4035.371 Million in the previous year, registering a growth of 16.27%.
Whereas during the year, the consolidated net revenue from operations increased from INR 33993.314 Million to INR 40112.287 Million with a growth of 18% and Profit after tax was at INR 5239.648 Million, recording an increase of 19.27% over the previous year.
FIXED ASSETS:
Tangible Assets
·
Buildings
·
Plant and Equipment
·
Furniture and Fixtures
·
Vehicles
·
Office Equipment
·
Computer Equipments
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject are
derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals have
been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
INR 63.50 |
|
|
1 |
INR 90.92 |
|
Euro |
1 |
INR 79.07 |
INFORMATION DETAILS
|
Information
Gathered by : |
GYT |
|
|
|
|
Analysis Done by
: |
VAR |
|
|
|
|
Report Prepared
by : |
IND |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.